These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29703489)

  • 1. Mechanisms and management of coagulopathy in acute promyelocytic leukemia.
    David S; Mathews V
    Thromb Res; 2018 Apr; 164 Suppl 1():S82-S88. PubMed ID: 29703489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coagulopathy of acute promyelocytic leukaemia revisited.
    Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
    Rodeghiero F; Castaman G
    Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
    Mantha S; Tallman MS; Soff GA
    Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
    Kwaan HC; Cull EH
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
    Breccia M; Lo Coco F
    Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
    Tallman MS; Abutalib SA; Altman JK
    Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
    Naymagon L; Mascarenhas J
    Leuk Res; 2020 Jul; 94():106356. PubMed ID: 32445941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique hemostatic dysfunction in acute promyelocytic leukemia.
    Kwaan HC
    Semin Thromb Hemost; 2014 Apr; 40(3):332-6. PubMed ID: 24590422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom.
    Tallman MS; Brenner B; Serna Jde L; Dombret H; Falanga A; Kwaan HC; Liebman H; Raffoux E; Rickles FR
    Leuk Res; 2005 Mar; 29(3):347-51. PubMed ID: 15661272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
    Ma G; Liu F; Lv L; Gao Y; Su Y
    Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.